Atlas Trials

Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib Hydrochloride

Clinical trial NCT01123460 · COMPLETED

Trial details

NCT number
NCT01123460
Sponsor
ECOG-ACRIN Cancer Research Group
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer
Start date
2010-04-12
Primary completion
2010-06-12
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.